Search Articles
Filter Articles
Sections
- All (3,093 articles)
- Pharma Events (45 articles)
- For Recruiters (234 articles)
- Careers Events (5 articles)
- Partners (3 articles)
- News (2,572 articles)
- Careers Advice (262 articles)
- Company Focus (118 articles)
- Company Career Hubs (1 article)
- Pharma Training (6 articles)
- 25 Years of PharmiWeb (13 articles)
- DE&I (1 article)
Found 3,093 articles
Ethics and GCP Forum
- 28 Feb 2024
The Institute of Clinical Research is delighted to announce the Spring Ethics and GCP Forum which will be in person on Friday 19th April at University College London.
About RSSL
- 28 Feb 2024
RSSL is a cutting-edge contract research organisation, pushing the boundaries of science and innovation to help make our world safer, healthier and more sustainable
Curia Appoints Steve Lavezoli as Vice President, Biologics
- 28 Feb 2024
Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26. Lavezoli will lead Curia’s biologics division, overseeing its discovery, development and manufacturing services.
About Curia
- 28 Feb 2024
Curia is a Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with biopharmaceutical customers to bring life-changing therapies to market. Our biologics and small molecule offerings span discovery through commercialization, with integrated regulatory and analytical capabilities.
A Recruiter’s Guide to Hiring a Pharmaceutical Product Manager
- 28 Feb 2024
In this guide, we explore the essential steps and considerations for you to keep in mind when searching for a pharmaceutical product manager. From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.
-
About TrakCel
- 28 Feb 2024
TrakCel is the market leading developer of integrated cell orchestration solutions and services.
Kalderos Attracts Two Recognized Industry Leaders to Board of Directors
- 27 Feb 2024
Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the addition of two experienced and highly respected industry veterans to its board of directors.
About Curve Therapeutics
- 27 Feb 2024
Curve Therapeutics is a private biotechnology company pioneering a revolutionary intracellular screening platform to enable the discovery of innovative therapeutics that address complex and challenging disease targets with the potential to transform the lives of patients
U.S. FDA Approves Expanded Indication for Gilead’s Biktarvy® to Treat People with HIV with Suppressed Viral Loads, Pre-existing Resistance
- 27 Feb 2024
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved a new, expanded indication for Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat people with HIV (PWH) who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. HIV treatment resistance is permanent and irreversible, which can jeopardize future treatment options for PWH.
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
- 27 Feb 2024
Boehringer Ingelheim today announced that up to 83.0% of adults treated with survodutide (BI 456906) achieved a statistically significant improvement of metabolic dysfunction-associated steatohepatitis (MASH) versus placebo (18.2%) in a Phase II trial [response difference: 64.8% (CI 51.1% - 78.6%), p<0.0001].2
GSK announces positive headline results from EAGLE-1 phase III trial for gepotidacin in uncomplicated urogenital gonorrhoea (GC)
- 27 Feb 2024
GSK plc (LSE/NYSE: GSK) today announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action for uncomplicated urogenital gonorrhoea in adolescents and adults.
Voydeya recommended for approval in the EU by CHMP as add-on treatment to ravulizumab or eculizumab for adults with PNH who have residual haemolytic anaemia
- 27 Feb 2024
Voydeya (danicopan) has been recommended for marketing authorisation in the European Union (EU) as an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who have residual haemolytic anaemia.
About PACE
- 22 Feb 2024
PACE is a new approach to tackling one of the world’s most complex health challenges – antimicrobial resistance (AMR). PACE’s ambition is to work with the AMR community to help progress early-stage antimicrobial drug and diagnostic projects with greater speed, support and confidence – giving the best AMR innovations the greatest chance of success.
Why Counteroffers Aren’t Always the Answer, and What You Can Do to Make Them Worthwhile
- 22 Feb 2024
Counteroffers are often used as a quick way of incentivising employees to stay in their current organisation, rather than accepting a new job offer elsewhere. Whilst they may motivate employees to stay in their current role in the short-term, more often than not they fail to address the real reasons why the employee was looking for a new role in the first place.
About Kling Biotherapeutics
- 22 Feb 2024
Kling Biotherapeutics boasts a fully owned IP portfolio featuring innovative platform technologies Kling-Select and Kling-Evolve. These cutting-edge technologies enable simultaneous discovery of novel targets and identification of fully human antibodies directly from patient-derived B cells.
About Mainz Biomed
- 21 Feb 2024
The Company’s flagship product is ColoAlert®, an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
Innovative Trials unveils initiative to boost clinical trial patient retention in pediatric studies
- 21 Feb 2024
A new initiative designed to boost clinical trial patient retention in pediatric studies has been announced today (19 February) by Innovative Trials, global specialists in clinical trial patient recruitment and retention acceleration.
The 3rd Conference on Clinical Studies with Medical Devices and IVDs (CSMD2024)
- 21 Feb 2024
CSMD2024 in London, UK, from May 29-30, 2024, for the 3rd Conference on Clinical Studies with Medical Devices and IVDs
What is Life Science?
- 21 Feb 2024
Life science is a branch of science that focuses on the study of living organisms. It encompasses various disciplines such as genetics, zoology, botany, microbiology, ecology, biochemistry, and physiology.
BiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s Total Artificial Heart
- 21 Feb 2024
BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.
